caldaret
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2002 (NCT00050076)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- CalciumMODULATOR
Calcium modulator
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ccc(N2CCNCC2)c(S(=O)(=O)O)c1- Mol. weight
- 256.33 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2106572 ↗
Also known as
- caldaret
- mcc135
- mcc 135
- mcc-135
- mcc-135
- mcc-135
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00078013 | Phase 2 | Apr 1, 2003 | Mitsubishi Tanabe |
| NCT00050076 | Phase 2 | Aug 1, 2002 | Takeda |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mitsubishi Tanabe | For profit | 1 | 1 | 1 | 2003 |
| Takeda | For profit | 1 | 1 | 1 | 2002 |
2 organizations
Page 1 / 1